Head and Neck Cancer Clinical Trial
Official title:
Carer eSupport: Rationale and Design of an Internet-based Support for Informal Caregivers of Individuals With Head and Neck Cancer
Verified date | February 2024 |
Source | Uppsala University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Informal caregivers to patients with head and neck cancer report that they are unprepared for caregiving, that they experience a high caregiver burden and a deteriorated health. The aim is to develop an internet based intervention for informal caregivers of individuals with head and neck cancer and evaluate the feasibility and acceptability of the intervention. The internet based intervention (Carer eSupport) will be based on scientific evidence, established theoretical frameworks and focus groups with caregivers and health care professionals. The feasibility and acceptability of Carer eSupport will be evaluated by 30 caregivers who will have access to Carer eSupport during one months. The feasibility and acceptability of Carer eSupport will be evaluated with quantitative and qualitative data.
Status | Completed |
Enrollment | 32 |
Est. completion date | September 30, 2023 |
Est. primary completion date | September 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Informal caregivers (defined by the patients) to patients with head and neck cancer who are about to start treatment, undergoing treatment or have completed treatment within the past month. Exclusion Criteria: - Confusion or dementia, inability to understand, speak or read Swedish. |
Country | Name | City | State |
---|---|---|---|
Sweden | Sahlgrenska university hospital | Göteborg | Västra Götaland |
Sweden | Örebro University Hospital | Örebro | Blekinge Län |
Sweden | Norrland University Hospital | Umeå | Västerbottens Län |
Sweden | Uppsala university hospital | Uppsala | Uppsala Län |
Lead Sponsor | Collaborator |
---|---|
Uppsala University | Region Örebro County, Region Västerbotten, Swedish Cancer Society, The Swedish Research Council, Uppsala University Hospital |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Inclusion rate | The proportion of caregivers who give informed consent for participation | 4 months | |
Primary | Utilization of Carer eSupport | The proportion of included caregivers who take use of Carer eSupport | 2 months | |
Primary | Attrition | The proportion of included caregivers who withdraw from the study | 3 months | |
Primary | Completion of questionnaires | The proportion of included caregivers who complete questionnaires | 3 months | |
Primary | Perceived feasibility | Qualitative data from semi-structured individual interviews exploring perceived feasibility of Carer eSupport. | Within 1 months after completion of testing Carer eSupport. | |
Primary | Perceived acceptability | Qualitative data from semi-structured individual interviews exploring perceived acceptability of Carer eSupport. | Within 1 months after completion of testing Carer eSupport. | |
Secondary | The Preparedness for caregiving scale | A brief 8-item self-report measure assessing preparedness for caregiving, a potential primary outcome in a future randomized controlled trial. | Assessed at baseline and at 1 months after access to Carer eSupport | |
Secondary | Caregiver´s burden scale | A 22-item self-report measure assessing caregiver burden, a potential primary outcome in a future randomized controlled trial. | Assessed at baseline and at 1 months after access to Carer eSupport. | |
Secondary | Short Form Health Survey (SF-36), v2. | A 36-item self-report measure assessing self-perceived health, a potential secondary outcome in a future randomized controlled trial. | Assessed at baseline and at 1 months after access to Carer eSupport. | |
Secondary | The Depression Anxiety Stress Scale-21 | A 21-item self-report measure assessing depression, anxiety, and stress, a potential secondary outcome in a future randomized controlled trial. | Assessed at baseline and at 1 months after access to Carer eSupport. | |
Secondary | The Multidimensional fatigue inventory | A 20-item self-report measure assessing five dimensions of fatigue, a potential secondary outcome in a future randomized controlled trial. | Assessed at baseline and at 1 months after access to Carer eSupport. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05808920 -
The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck
|
||
Completed |
NCT02526017 -
Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers
|
Phase 1 | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT03997643 -
Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT04700475 -
Effect of Low Level Laser Therapy on Prevention of Radiotherapy Induced Xerostomia in Cancer Patients.
|
N/A | |
Withdrawn |
NCT04058145 -
AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma
|
Phase 2 | |
Completed |
NCT02572869 -
Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free Flaps
|
||
Active, not recruiting |
NCT04474470 -
A Study to Evaluate NT219 Alone and in Combination With ERBITUX® (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer
|
Phase 1/Phase 2 | |
Withdrawn |
NCT05073809 -
Photoacoustic Imaging of Head and Neck Tumours
|
||
Active, not recruiting |
NCT04383210 -
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
|
Phase 2 | |
Active, not recruiting |
NCT03651570 -
Randomized Controlled Trial of a E-intervention to Help Patients Newly Diagnosed With Cancer Cope Better: Pilot Study
|
N/A | |
Recruiting |
NCT04930432 -
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06016699 -
Immunological Function After Radiation With Either Proton or Photon Therapy
|
||
Terminated |
NCT03843554 -
Commensal Oral Microbiota in Head and Neck Cancer
|
N/A | |
Recruiting |
NCT05915572 -
Mulligan Technique on Shoulder Dysfunction
|
N/A | |
Completed |
NCT05897983 -
Tens and Rocabado Exercises on TMJ Dysfunction
|
N/A | |
Not yet recruiting |
NCT06289049 -
Heavy Strength Training in Head and Neck Cancer Survivors
|
Phase 2 | |
Withdrawn |
NCT05263648 -
Virtual Reality Software to Reduce Stress in Cancer Patients
|
N/A | |
Withdrawn |
NCT03238638 -
A Study of Epacadostat + Pembrolizumab in Head and Neck Cancer Patients, Who Failed Prior PD-1/PD-L1 Therapy
|
Phase 2 |